Baxdela
Active Ingredient(s): DelafloxacinFDA Approved: * June 19, 2017
Pharm Company: * MELINTA THERAPEUTICS INC
Category: Antibiotics
Delafloxacin sold under the brand name Baxdela among others, is a fluoroquinolone antibiotic used to treat acute bacterial skin and skin structure infections.[1] Contents 1 Medical use 2 Adverse effects 3 Interactions 4 Pharmacology 5 Chemistry 6 History 7 References 8 External links Medical use Delafloxacin is indicated to treat adults with acute bacterial skin and skin structure infections (ABSSSI) caused by designated susceptible bacteria or adults with community-acq... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.